InsidersTradesSigma
Follow the Akers Biosciences Inc stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €5.4bn. The latest transaction was reported on 6 January 2016 (Acquisition). Among the most active insiders: Knox Thomas J. Every trade is openly available.
Analysts rate Akers Biosciences Inc Hold (neutral), based on 2 analysts. Average price target: US$463.00.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Akers Biosciences Inc is a company focused on developing medical diagnostic technologies. It specializes in innovative solutions for rapid and accurate testing.